English
Specials
    Go Ad-Free
    My Alerts
    Moneycontrol
    Moneycontrol PRO
    Loans
    Loans
    HomeNewsJhssvendgaardlaboratories

    Jump to
    • JHS Svendgaard expect to clock 20-30% revenue growth in FY18

      JHS Svendgaard expect to clock 20-30% revenue growth in FY18

      In an interview to CNBC-TV18, Nikhil Nanda, MD of JHS Svendgaard Laboratories gave his outlook for the year.

    • JHS Svendgaard Labs to become profitable in FY17: MD

      JHS Svendgaard Labs to become profitable in FY17: MD

      The company is now focusing on shifting focus from being pure contract manufacturers to owing brands, says Nikhil Nanda, MD of the company.

    • Will repay unsecured loans with Rs 30 cr warrant: JHS Svendgaard

      Will repay unsecured loans with Rs 30 cr warrant: JHS Svendgaard

      Nikhil Nanda, MD, JHS Svendgaard Laboratories says the dilution of the company will be such that the promoter stake will rise to 45 percent from the current 37 percent.

    • JHS Svendgaard hikes prices to protect margins

      JHS Svendgaard hikes prices to protect margins

      In an interview to CNBC-TV18, Nikhil Nanda, managing director of JHS Svendgaard Laboratories says, the company has taken price hike to protect its margins.

    • JHS Svendgaard to generate 20-25% rev from exports in 1yr

      JHS Svendgaard to generate 20-25% rev from exports in 1yr

      JHS Svendgaard rallied as the company planned to resume export of tooth brushes. It had also closed a deal with Amway to sell the tooth brushes. The company hiked prices by the end of this quarter on account of increase in raw material based on the input material that it uses for each of the customers.

    • Will maintain volumes despite margin strain: JHS Svendgaard

      Will maintain volumes despite margin strain: JHS Svendgaard

      Nikhil Nanda, managing director, JHS Svendgaard in an interview to CNBC-TV18 said, the company's margins are under tremendous pressure because of prices of most of its raw materials are increasing on a regular basis.

    • Tano Mauritius will hold around 14.8% in co: JHS Svendgaard

      Tano Mauritius will hold around 14.8% in co: JHS Svendgaard

      JHS Svendgaard Laboratories has decided to do a preferential allotment of 25,00,000 equity shares to Tano Mauritius India FVCI at a price of Rs. 97.75. Tano Mauritius will hold about 14.8% in the company, Nanda says.

    • Plan to release pledged shares by FY12-13: JHS Svendgaard

      Plan to release pledged shares by FY12-13: JHS Svendgaard

      Nikhil Nanda, MD of JHS Svendgaard, in an interview with CNBC-TV18’s Reema Tendulkar and Ekta Batra, spoke about the recent happenings in the company and the future ahead.

    Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347